melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling
Melior Discovery
home
Our Services
High Throughput In Vivo Pharmacology:
Discovery Services:
Our Technology
 
 

theraTRACE

Melior Pharmaceuticals

              

 

             

 

                 

melior melior melior discovery melior pharmaceuticals preclinical services pre-clinical services in vivo pharmacology in vivo efficacy efficacy models pharmacokinetics indications discovery specialized animal models bioanalytical services theratrace exton pennsylvania cro contract research drug discovery drug development metabolic disease alzheimer’s alzheimers diabetes reprofiling

Our Technology assay applications

 
   

Melior's theraTRACE® discovery platform includes over 35 standardized and validated models relevant to the following indications/therapeutic areas:

  • Neurodegenerative Diseases
    • Epilepsy
    • Multiple Sclerosis
    • Alzheimer's disease*
    • Parkinson's disease
  • Psychiatry
    • Anxiety
    • Addiction
    • Depression
  • General Neurology
    • Irwin Evaluations
    • Locomotor Activity
    • Circadian Rhythm
    • Thermoregulation
  • Pain
    • Mechanical
    • Thermal
    • Chemical
    • Visceral
  • Inflammation
    • Arthritis
    • Asthma
    • Sepsis
  • Neuroinflammation
    • Multiple Sclerosis
  • Cardiovascular
    • Hypertension
    • Thrombosis
    • Small Animal Telemetry
  • Metabolic Disease
    • Diabetes (type II)
    • Metabolic Syndrome
    • Obesity
  • Gastrointestinal
    • Irritable Bowel Syndrome
    • Morphine-induced constipation
  • Immunology
    • Allergic reaction
    • Monocyte infiltration
  • Urology
    • Overactive Bladder

* Amyloid Plaque Deposition - Exclusive Model

 

Back to top of page